Kistler-Tiffany Companies’s Novo Nordisk NVO Stock Holding History

Kistler-Tiffany Companies’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$20.6K	Buy	254 +36	+17%	+$2.94K	﹤0.01%	613
2023 Q1	$17.4K	Hold	218	–	–	﹤0.01%	570
2022 Q4	$14.7K	Hold	218	–	–	﹤0.01%	580
2022 Q3	$11K	Buy	218 +2	+0.9%	+$107	﹤0.01%	584
2022 Q2	$12K	Buy	216 +2	+0.9%	+$111	﹤0.01%	567
2022 Q1	$12K	Hold	214	–	–	﹤0.01%	577
2021 Q4	$12K	Hold	214	–	–	﹤0.01%	571
2021 Q3	$10K	Hold	214	–	–	﹤0.01%	587
2021 Q2	$9K	Buy	214 +2	+0.9%	+$78	﹤0.01%	578
2021 Q1	$7K	Hold	212	–	–	﹤0.01%	555
2020 Q4	$7K	Hold	212	–	–	﹤0.01%	532
2020 Q3	$7K	Hold	212	–	–	﹤0.01%	512
2020 Q2	$7K	Buy	+212	New	+$6.76K	﹤0.01%	480
2017 Q1	–	Sell	-70	Closed	-$1K	–	523
2016 Q4	$1K	Hold	70	–	–	﹤0.01%	505
2016 Q3	$1K	Hold	70	–	–	﹤0.01%	535
2016 Q2	$2K	Sell	70 -838	-92%	-$23K	﹤0.01%	553
2016 Q1	$25K	Buy	908 +10	+1%	+$268	0.01%	331
2015 Q4	$26K	Hold	898	–	–	0.01%	338
2015 Q3	$24K	Hold	898	–	–	0.01%	331
2015 Q2	$25K	Buy	898 +8	+0.9%	+$225	0.02%	349
2015 Q1	$24K	Buy	890 +820	+1,171%	+$18.9K	0.02%	336
2014 Q4	$1K	Hold	70	–	–	﹤0.01%	564
2014 Q3	$2K	Sell	70 -12	-15%	-$276	﹤0.01%	555
2014 Q2	$2K	Sell	82 -8	-9%	-$177	﹤0.01%	531
2014 Q1	$2K	Hold	90	–	–	﹤0.01%	527
2013 Q4	$2K	Hold	90	–	–	﹤0.01%	533
2013 Q3	$2K	Hold	90	–	–	﹤0.01%	529
2013 Q2	$1K	Buy	+90	New	+$1.5K	﹤0.01%	559

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kistler-Tiffany Companies's NVO Position: Q2 2023 in Review

Kistler-Tiffany Companies increased its Novo Nordisk (NVO) stake by 17% in Q2 2023, buying an estimated $2.94K and bringing the position to 254 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #613.

Kistler-Tiffany Companies first reported a position in NVO in Q2 2013 and has held it in 28 quarters since. The position peaked at $26K in Q4 2015. 1,198 funds tracked by Wall St. Rank hold NVO as of Q2 2023.

Kistler-Tiffany Companies held 254 shares of Novo Nordisk worth $20.6K as of Q2 2023.
Kistler-Tiffany Companies bought 36 Novo Nordisk shares in Q2 2023, an estimated $2.94K.
Novo Nordisk made up ﹤0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #613 holding.
Kistler-Tiffany Companies first reported a position in Novo Nordisk in Q2 2013 and has held it in 28 quarters since.
Kistler-Tiffany Companies's Novo Nordisk position peaked at $26K in Q4 2015.
1,198 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.